Table 1.

Summary Statistics of Included Articles

Characteristic
Sample size Weight (kg)	15 ± 11 26 ± 12
Sex
Male Female Both Not specified	3 (5%) 45 (71%) 3 (5%) 12 (20%)
Age
< = 1 month 1–3 months 3–6 months 6 months to 1 year >1 year Not specified	0 6 (10%) 15 (24%) 5 (8%) 1 (2%) 36 (67%)
Location
Cervical Thoracic Lumbar Multiple levels Not specified	3 (5%) 50 (80%) 7 (11%) 2 (3%) 1 (1%)
Time to end-point
Non-survival < = 1 day 1 day to 1 week 1 week to 1 month 1–3 months 3–6 months 6 months to 1 year Multiple time points	16 (25%) 8 (13%) 5 (8%) 2 (3%) 16 (25%) 7 (11%) 3 (5%) 6 (10%)
Injury method
Weight drop with compression Computer-controlled impactor Weight drop Surgical clips Transection Balloon inflation Hemisection Electrocautery Gunshot Other	27 (43%) 7 (11%) 10 (16%) 4 (6%) 3 (5%) 3 (5%) 2 (3%) 2 (3%) 2 (3%) 3 (5%)
Rehabilitation (if survival surgery, n = 47)
Received Did not specify	10 (21%) 37 (79%)
Interventions
None MAP augmentation Electrical stimulation Stem cell therapy Hypothermia Biomaterials Gene therapy Steroid Nanoparticles Other	33 (52%) 7 (11%) 6 (10%) 5 (8%) 2 (3%) 2 (3%) 2 (3%) 1 (2%) 1 (2%) 4 (6%)

MAP, mean arterial pressure.